Neuroendocrine Tumors

Radiate Resilience: Neuroendocrine Tumors, Where Hope Takes Root

Welcome to Universal Hospital’s Neuroendocrine Tumor (NET) Care, where we are dedicated to providing specialized and compassionate care for individuals affected by neuroendocrine tumors. Neuroendocrine tumors are a group of rare tumors that arise from cells of the neuroendocrine system.

Understanding Neuroendocrine Tumors:

Neuroendocrine tumors (NETs) are a group of rare tumors that originate in the neuroendocrine cells, which are found throughout the body and have characteristics of both nerve cells and hormone-producing cells. These tumors can develop in various organs, including the lungs, pancreas, gastrointestinal tract, and other parts of the body.

Types of Neuroendocrine Tumors:

  • Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs):
    • Pancreatic NETs: Arise in the pancreas.
    • Gastrointestinal NETs: Occur in the stomach, small intestine, colon, and rectum.
  • Bronchopulmonary Neuroendocrine Tumors:
    • Carcinoid Tumors: Typically found in the lungs or digestive tract.
  • Thymic and Mediastinal Neuroendocrine Tumors:
    • Arise in the thymus or mediastinum.
  • Other Neuroendocrine Tumors:
    • NETs can also develop in other organs, such as the ovaries, testes, or skin.
Neuroendocrine Tumors

Risk Factors:

  • Age: Small intestine cancer is more common in older adults.
  • Genetic Conditions: Certain genetic disorders, such as familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC), may increase the risk.
  • Crohn’s Disease: Inflammatory bowel diseases, including Crohn’s disease, may be associated with a higher risk.
  • Celiac Disease: Long-standing celiac disease may increase the risk.
  • Smoking: Tobacco use is considered a risk factor.

Symptoms:

The symptoms of small intestine cancer can be nonspecific and may include:

  • Abdominal Pain: Discomfort or pain in the abdomen.
  • Unexplained Weight Loss: Significant weight loss without an apparent cause.
  • Fatigue: Persistent tiredness.
  • Changes in Bowel Habits: Diarrhea, constipation, or changes in stool consistency.
  • Abdominal Mass: Palpable lump or mass in the abdomen.

Staging:

Small intestine cancer is staged based on the extent of its spread, ranging from Stage I (localized) to Stage IV (advanced and metastatic).

  • Stage 0: Carcinoma in situ, where abnormal cells are found only in the innermost layer of the small intestine.
  • Stage I: Cancer is confined to the inner lining of the small intestine.
  • Stage II: Cancer involves deeper layers of the small intestine or adjacent tissues.
  • Stage III: Cancer has spread to nearby lymph nodes.
  • Stage IV: Cancer has metastasized to distant organs or lymph nodes.

Diagnosis:

  1. Imaging Tests: CT scans, MRI, or capsule endoscopy to visualize the small intestine.
  2. Biopsy: Removal of a tissue sample for laboratory examination to confirm cancer.
  3. Endoscopy: A procedure using a flexible tube with a camera to examine the inside of the small intestine.

Treatment:

Treatment depends on the type, stage, and location of small intestine cancer and may include:

  1. Surgery: Removal of the cancerous tissue, which may involve resection of a portion of the small intestine.
  2. Chemotherapy: Medications that kill or inhibit the growth of cancer cells.
  3. Radiation Therapy: High-dose X-rays or other forms of radiation to target and destroy cancer cells.
  4. Targeted Therapy: Medications targeting specific molecules involved in cancer growth.

Prevention:

Preventive measures for small intestine cancer may include:

  • Healthy Lifestyle: Maintaining a healthy diet and lifestyle.
  • Screening for Genetic Conditions: Individuals with a family history of genetic conditions associated with small intestine cancer may benefit from genetic counseling and screening.

Prognosis:

  • Prognosis for small intestine cancer varies based on factors such as the type, stage at diagnosis, response to treatment, and overall health. Due to its rarity, prognosis can be more challenging to predict.

Follow-Up:

  • Regular follow-up care is essential for monitoring the response to treatment, managing side effects, and detecting any signs of recurrence.

Why Choose Universal Hospital for Small Intestine Cancer Care:

  • Expert Gastrointestinal Oncology Team: Our Small Intestine Cancer Care Center is staffed by a team of experienced gastroenterologists, oncologists, surgeons, and supportive care professionals with specialized knowledge in the diagnosis and treatment of small intestine cancer.
  • Cutting-Edge Treatments: Universal Hospital offers state-of-the-art treatments, including surgery, chemotherapy, targeted therapy, and personalized care plans, ensuring patients have access to the latest advancements in small intestine cancer care.
  • Holistic Patient Care: We prioritize individualized care plans that consider not only the medical aspects of small intestine cancer but also the emotional and practical needs of our patients, providing support and resources beyond the treatment room.

Senior Consultant Oncosurgeon

Consultant Oncosurgeon

Consultant Oncosurgeon

CANCER SPECIALIST

Cancer Specialist

Your Questions, 

Our Expertise 

 
Let’s Connect for a Healthier Tomorrow!